Search Mailing List Archives

Limit search to: Subject & Body Subject Author
Sort by: Reverse Sort
Limit to: All This Week Last Week This Month Last Month
Select Date Range     through    

[bioontology-support] Agenda Available Online for the 6th Immunotherapeutics & Immunomonitoring Conference

Novel Immunotherapeutics Summit 2014 nits at
Thu Oct 24 17:31:21 PDT 2013

If you can't view this page, please visit: JMEL-25246
Mark Your Calendars! Plan to attend the 6th Immunotherapeutics & Immunomonitoring Conference
January 29-31, 2014 in San Diego, CA 
Register with the early registration discount and save up to $400 
Submit an abstract to participate in the conference 

Dear Colleague,

Network with leading experts from the scientific and clinical arenas as well as investigators in industry to discuss novel findings and developments in immunological assays and procedures. Learn about recent advances in immunotherapy, as they relate to various modalities, specific cancers, cell subsets, and animal models. Potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories will also be discussed.

The 6th Immunotherapeutics & Immunomonitoring Conference, to be held on January 29-31, 2014 in San Diego, CA., highlights cutting edge research, immuno-strategies and novel therapeutics against various diseases.

Session topics include:
     Disease & Tumor Microenvironment
     Novel Therapeutics & Targets
     Combinatorial Immunotherapies
     Overcoming Challenges in Clinical Development

Register today and receive 20% off the registration price.
Bring 3 people for the price of 2 with discount code rcdvb.

The 6th Immunotherapeutics and Immunomonitoring is part of the Novel Immunotherapeutics Summit 2014, which includes the following concurrent tracks:

12th Cytokines & Inflammation
2nd Immunogenicity & Immunotoxicity
Inaugural Innate Immunity

Registration to the Summit gives access to all 4 co-located conferences:


Michael Kalos, Translational & Correlative Studies Laboratory, University of Pennsylvania - KEYNOTE

Jeffrey Abbey, President, Chief Executive Officer, Argos Therapeutics

Damien Bresson, Scientist & Project Leader, Ambrx

Kate Broderick, Director of Research & Development, Inovio

Christine Brown, Associate Research Professor; Associate Director, T cell Therapeutics Research Laboratory, City of Hope National Medical Center

Lisa H. Butterfield, Associate Professor of Medicine, Surgery & Immunology; Director, UPCI Immunologic Monitoring & Cellular Products Laboratory, University of Pittsburgh

Pirouz Daftarian, Research Assistant Professor of Microbiology and Immunology, University of Miami

Iqbal Grewal, Chief Scientific Officer, ImmunGene Inc.

Jane Grogan, Senior Scientist, Immunology, Genentech

Jose Guevara-Patino, Associate Professor, Oncology Institute, Loyola University

Christopher Heery, Staff Clinician, Clinical Trials Group, Tumor Immunology & Biology, NIH, National Cancer Institute

Roman Kischel, Principal Scientist, Amgen

Keith Knutson, Associate Professor, Immunology, Mayo Clinic

Michael Locker, Medical Director, Dendreon

Marc Mansour, Chief Scientific Officer, ImmunoVaccine

Doug McNeel, Professor, Medicine, University of Wisconsin-Madison

Paul Moore, Vice President, Cell Biology & Immunology, Macrogenics

Laszlo Radvanyi, Professor, UT MD Anderson Cancer Center

Thomas Schall, President and Chief Executive Officer, Chemocentryx

Jeffrey Ulmer, Global Head, External Research, Novartis

Steffen Walter, Director & Head, Immunology Immatics Biotechnologies GmbH

Albert Wong, Professor; Director, Brain Tumor Research Laboratories, Stanford University Medical Center

Jianda Yuan, Assistant Lab Member, Immune Monitoring Core, Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center

View the speakers webpage for the most updated list of speakers.
To be considered for an oral presentation, please submit an abstract by December 29, 2013. Selected presentations will be based on quality of abstract and availability. Presentation slots fill up fast so please submit your abstract soon.  
For business development & exhibiting opportunities, contact Amber Kempf, 626-256-6405 x110 or spex at 


Please visit to view our upcoming conferences.
This advertisement is sent to support at from GTC, 635 W. Foothill Blvd, Monrovia, CA 91016. If you prefer not to receive further messages from this sender, please forward this email to remove at or use the following link to unsubscribe 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <>

More information about the bioontology-support mailing list